An in vitro evaluation of endodontic sealers and an antibiotic to assess their antimicrobial effect against Enterococcus faecalis.

Objective: This study aimed to compare the antimicrobial effect of three endodontic sealers (AH Plus, Mineral trioxide aggregate [MTA] Fillapex, and BioRoot RCS) with and without amoxicillin against E. faecalis. Methodology: Amoxicillin, equivalent to 10% of the sealers' total weight, was mixed with the sealers. Another batch was prepared without amoxicillin. The direct contact test (DCT) and the agar diffusion test were used to assess the antibacterial effect. Results were analysed using one-way analysis of variance (ANOVA), the F-test, and the Kruskal-Wallis test. Results: AH Plus significantly suppressed E. faecalis without the addition of amoxicillin in the DCT (p = 0.011), while in the agar diffusion test, BioRoot RCS had a larger inhibition zone than the control (p < 0.001). When amoxicillin was added to the sealers, AH Plus (p = 0.003) and MTA Fillapex (p = 0.042) reduced E. faecalis growth. In contrast, all three sealers showed larger inhibition zones than the control (p = 0.001), with AH Plus displaying a larger inhibition zone than MTA Fillapex (p = 0.042) and BioRoot RCS (p = 0.032). Conclusions: It was thus concluded that the addition of amoxicillin to endodontic sealers enhances their antimicrobial activity against E. faecalis.

Antimicrobial effectiveness of root canal sealers against Enterococcus faecalis.

We evaluated four root canal sealers to determine their antimicrobial effectiveness against E. faecalis. The direct contact test was used to measure the effectiveness of the study materials and close contact between bacteria on the kinetics of bacterial growth. The agar diffusion test (ADT) was also performed for comparison. Using one-way ANOVA and the F-test, significant differences between the sealers were confirmed. Whereas BioRoot endodontic sealer had an antimicrobial effect statistically similar to the zinc oxide-eugenol control (p=.99), EndoSequence sealer and AH Plus sealer both had a significantly lower antimicrobial effect than the control (p=.0000266 and p=.0000068, respectively).

Implants failures related to endodontic treatment. An observational retrospective study.

OBJECTIVE: The aim of the study was to analyze potential etiological risk factors that constitute a complex problem in the clinical management of peri-implantitis. MATERIALS AND METHODS: An observational retrospective study was conducted to describe the possible effect of lesions of origin pulpar and/or periapical success or failure of the implant. The sample consisted of review of 800 implants, of which 500 were conducted at the Faculty of Dentistry of the UANL and 300 private clinics of Maxillofacial surgeons experienced in the placement of those who reside in Monterrey, Mexico. Five hundred and eighty cases correspond to female patients while that 220 patients of the male gender. The age of patients at the time of placing the implant ranged from 28 to 81 years. RESULTS: Of 800 study subjects who underwent dental implant treatments, 200 cases (25%) were detected which presented endodontic failure prior and/or adjacent to the placement of the implant. The 50.41% had peri-implantitis, recording 62 cases in the Faculty and 18 cases (23.38%) in private clinics, finding that there was a statistically significant difference between the presence and absence of peri-implantitis in terms of failed endodontic prior and/or adjacent to the placement of the implant. CONCLUSIONS: Within the limitations of this observational retrospective study, it could be concluded that the development of inflammatory changes mediated by the presence of remnant bacteria surrounding hard tissues adjacent to implants might induce late failures of implants, and potentially trigger pathological features of apical peri-implantitis.

Melatonin: bone metabolism in oral cavity.

Throughout life, bone tissue undergoes a continuous process of resorption and formation. Melatonin, with its antioxidant properties and its ability to detoxify free radicals, as suggested by Conconi et al. (2000) may interfere in the osteoclast function and thereby inhibit bone resorption, as suggested by Schroeder et al. (1981). Inhibition of bone resorption may be enhanced by a reaction of indoleamine in osteoclastogenesis. That it has been observed melatonin, at pharmacological doses, decrease bone mass resorption by suppressing through down regulation of the RANK-L, as suggested by Penarrocha Diago et al. (2005) and Steflik et al. (1994). These data point an osteogenic effect towards that may be of melatonin of clinical importance, as it could be used as a therapeutic agent in situations in which would be advantageous bone formation, such as in the treatment of fractures or osteoporosis or their use as, a bioactive surface on implant as suggested by Lissoni et al. (1991).